Prostate

Prostate

Lowering prostate most cancers therapy dosage alleviates downsides whereas remaining efficient – Well being Imaging

Editor - July 28, 2024

Lowering prostate most cancers therapy dosage alleviates downsides whereas remaining efficient Well being Imaging

Prostate

Telix’s prostate most cancers imaging package set for FDA assessment

Editor - July 28, 2024

Prostate

TLX007-CDx underneath FDA evaluate for approval in prostate most cancers

Editor - July 28, 2024

The FDA has accepted the submitting of a brand new drug utility (NDA) searching for approval of TLX007-CDx, an investigational chilly package for...

Prostate

FDA Accepts Telix NDA for New Prostate Most cancers Imaging Agent

Editor - July 28, 2024

July 24, 2024 — Telix Prescribed drugs Restricted introduced that the USA (U.S.) Meals and Drug Administration (FDA) has accepted the submitting of its New Drug Software...

Prostate

Dr. Helfand on escalation/de-escalation of therapy based mostly on PSMA-PET

Editor - July 28, 2024

On this interview, Brian T. Helfand, MD, PhD, discusses the position of PSMA-PET imaging in tailoring therapy plans for sufferers with prostate most...

Hot Topics

How the Seasons Encourage Hope and Therapeutic By way of Most cancers

Breastfeeding After Breast Most cancers Proves Secure in Early Trial Outcomes

Constructing Belief With Your Oncologist and Accessing Scientific Trials

Quick Links

Must Read

How the Seasons Encourage Hope and Therapeutic By way of Most cancers

Breastfeeding After Breast Most cancers Proves Secure in Early Trial Outcomes

Constructing Belief With Your Oncologist and Accessing Scientific Trials

Lung Most cancers Threat in Non-People who smoke: Consciousness and Genetic Testing

Popular Articles

How the Seasons Encourage Hope and Therapeutic By way of Most cancers

Breastfeeding After Breast Most cancers Proves Secure in Early Trial Outcomes

Constructing Belief With Your Oncologist and Accessing Scientific Trials